While the UK has decided to shorten the gap between Covishield doses, the Centre stood by its decision to increase the gap, and said it was based on assessment of experts and no controversy be created over suspected vaccine shortages.
“They (UK) are taking decisions based on their situation, mutant, pandemic…We have taken it as per our risk epidemiology. We are driven by science. It is a dynamic process. We will keep any eye… we will find out the basis of their decision,” Niti Aayog member-health Dr V K Paul said.
The government said the expert group’s assessment is that even a single dose is 60-85% effective in disease prevention (collectively for mild, moderate and severe) and inhibits transmissibility.